Form 4: Amphastar Pharmaceuticals Director Richard K. Prins Acquires Shares and Stock Options

Director Richard K. Prins acquired 3,076 shares of common stock and 6,864 stock options in Amphastar Pharmaceuticals on June 3, 2024.

Summary

• Richard K. Prins, a director at Amphastar Pharmaceuticals, acquired 3,076 shares of common stock on June 3, 2024.
• These shares were acquired at a price of $0.
• Following the transaction, Prins directly owns 33,971 shares of common stock.
• Prins also acquired 6,864 stock options with an exercise price of $42.25 on the same date.
• These options vest on June 3, 2025, and expire on June 3, 2034.
• The shares acquired are represented by restricted stock units (RSUs) which vest on June 3, 2025.
• Following the transaction, Prins directly owns 6,864 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying can be a positive signal, but the details of the vesting schedule and the overall context need to be considered.

Positives

• The acquisition of shares and stock options by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future performance.

Stakeholder Impact

• The acquisition of shares and stock options by a director may positively influence shareholder confidence.

Key Dates